Srinath Sanda - Concepedia

Author

Srinath Sanda

Also Known As

Angela Lam, Isabella Niu, Karen Ko, Martha Rangel-Lugo, Nowak-Wegrzyn, Anna, S Sanda, S. L. Sanda, S. SANDA, S. Sanda, Sailaja Sanda

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

Benaroya Research Institute University of Washington University of California, San Francisco Virginia Mason Medical Center Immune Tolerance Network

About

Srinath Sanda is an author at Benaroya Research Institute specializing in medicine, immunology, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	1.4K
2	Allergy	5	6	252
3	Natural Sciences	3	3	142
4	Engineering	1	1	26
5	Health Sciences	1	1	36

Srinath Sanda

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials Antoinette Moran, Brian N. Bundy, Dorothy Becker, The Lancet InflammationMetabolic SyndromeType 1Diabetes ManagementAutoimmune Disease	2013	351
Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function S. Alice Long, Mary Rieck, Srinath Sanda, Diabetes	2012	306
Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1 Jenny E. Kanter, Farah Kramer, Shelley Barnhart, Proceedings of the National Academy of Sciences Acyl-coa Synthetase 1ImmunologyInflammatory Macrophage PhenotypeInflammationMetabolic Syndrome	2012	300
The Effector T Cells of Diabetic Subjects Are Resistant to Regulation via CD4+FOXP3+ Regulatory T Cells Anya Schneider, Mary Rieck, Srinath Sanda, The Journal of Immunology	2008	294
Defects in IL-2R Signaling Contribute to Diminished Maintenance of FOXP3 Expression in CD4+CD25+ Regulatory T-Cells of Type 1 Diabetic Subjects S. Alice Long, Karen Cerosaletti, Paul L. Bollyky, Diabetes	2009	274
Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial Stephen E. Gitelman, Brian N. Bundy, Ele Ferrannini, The Lancet Diabetes & Endocrinology	2021	123
Altered B Cell Homeostasis Is Associated with Type I Diabetes and Carriers of the PTPN22 Allelic Variant Tania Habib, Andrew Funk, Mary Rieck, The Journal of Immunology Ptpn22 Allelic VariantT-regulatory CellImmunologyB Cell ToleranceCell Death	2011	119
Use of a “Fuzzy Logic” Controller in a Closed-Loop Artificial Pancreas Richard Mauseth, Irl B. Hirsch, Robert Kircher, Diabetes Technology & Therapeutics	2013	109
Differential induction of allergen-specific IgA responses following timothy grass subcutaneous and sublingual immunotherapy Mohamed H. Shamji, David Larson, Aarif O. Eifan, Journal of Allergy and Clinical Immunology	2021	90
Insulin gene VNTR genotype associates with frequency and phenotype of the autoimmune response to proinsulin Ivana Durinovic‐Belló, Rebecca P. Wu, Vivian H. Gersuk, Genes and Immunity	2010	88

Page 1